此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

头皮阻滞对开颅手术患者术中血流动力学及术后疼痛的影响

2026年9月28日 更新者:Kazi Mahzabin Arin、Bangladesh Medical University

颅骨切开术患者术中血流动力学反应及术后镇痛的头皮阻滞疗效

The goal of this clinical trial is to learn if an ultrasound-guided scalp block can improve intraoperative hemodynamic stability and provide better postoperative pain relief in adult patients undergoing elective supratentorial craniotomy. The main questions it aims to answer are:

Does ultrasound-guided scalp block reduce changes in heart rate and blood pressure during surgery compared with surgical site infiltration?

Does ultrasound-guided scalp block decrease postoperative pain and opioid requirements in the first 24 hours after craniotomy?

Researchers will compare patients receiving an ultrasound-guided scalp block to those receiving standard surgical site infiltration to see if the scalp block provides better perioperative hemodynamic control and postoperative analgesia.

Participants will:

Receive general anesthesia with either ultrasound-guided scalp block or surgical site infiltration

Have heart rate, blood pressure, and other hemodynamic parameters monitored throughout surgery

Receive standard postoperative pain management, with pain scores recorded at 0, 2, 6, 12, and 24 hours

Receive opioids as needed based on pain scores, with total opioid consumption and time to first analgesic dose recorded

Be monitored for adverse events, including nausea, vomiting, sedation, and block-related complications

研究概览

详细说明

This clinical trial is designed to evaluate whether an ultrasound-guided scalp block improves outcomes in adult patients undergoing elective craniotomy. Craniotomy, a surgical procedure to access the brain, can be associated with significant pain and stress responses during and after surgery. Painful events such as intubation, placement of skull pins, skin incision, and manipulation of the scalp and dura can cause rapid increases in heart rate and blood pressure, which may be harmful, especially in patients with brain injuries or compromised cerebral blood flow.

Currently, these hemodynamic changes are often managed with general anaesthesia and systemic medications such as opioids. However, opioids can delay recovery, cause nausea and vomiting, and interfere with neurological assessments after surgery. Regional anaesthesia techniques, like a scalp block, can reduce the body's stress response to surgery, provide better pain relief, and decrease the need for systemic pain medications. Ultrasound guidance allows anesthesiologists to locate nerves more accurately and perform the block safely, reducing potential complications.

In this study, participants will be randomly assigned to one of two groups. One group will receive a standard surgical site infiltration with local anaesthetic, while the other group will receive an ultrasound-guided scalp block in addition to general anaesthesia. All participants will be closely monitored during surgery, with measurements of heart rate, blood pressure, and other vital signs taken at key points, including before induction, during intubation, at skull pin placement, at skin incision, and at skin closure.

After surgery, participants will receive routine pain management and will be monitored for the first 24 hours. Pain levels will be recorded at multiple time points, and the total use of opioid pain medications, time to first analgesic, and any side effects or complications will be documented.

The main goal of the study is to determine whether the ultrasound-guided scalp block can provide better control of heart rate and blood pressure during surgery and improve postoperative pain relief compared with surgical site infiltration. Secondary goals include assessing the amount of pain medication needed after surgery and the incidence of any side effects, such as nausea, vomiting, or sedation.

Results from this study may help improve patient comfort, reduce complications, and optimize pain management strategies for patients undergoing brain surgery.

研究类型

介入性

注册 (估计的)

72

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 64年 (成人)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18-64 years.
  • ASA (American Society of Anesthesiologists) physical status I or II.
  • Patients scheduled for elective supratentorial craniotomy.
  • BMI of 18 to 30 kg/m².
  • GCS score of 9 to 15.

Exclusion Criteria:

  • Patient with instable blood pressure and heart rate.
  • Known allergy or hypersensitivity to local anesthetics.
  • Coagulation disorders or current anticoagulant therapy.
  • Infection at the injection site or systemic infection.
  • Patients with open skull defects.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:Group Surgical site infiltration (SSI)

Participants in this group will receive standard general anesthesia for elective supratentorial craniotomy. In addition, local anesthetic will be administered via surgical site infiltration.

Participants receiving this intervention will undergo local anesthetic infiltration at the planned surgical sites in addition to standard general anesthesia for elective supratentorial craniotomy.

Drug: Bupivacaine 0.5% plain solution

Dosage: 10-15 ml along the incision line plus 5 ml at each pin insertion site

Dosage Form: Injectable solution

Route: Subcutaneous and deep infiltration into the scalp

Timing: Single administration immediately after induction of general anesthesia, prior to surgical incision

实验性的:Group Scalp block

Participants in this group will receive standard general anesthesia for elective supratentorial craniotomy. In addition, they will receive an ultrasound-guided scalp block targeting the major nerves of the scalp.

Participants receiving this intervention will undergo ultrasound-guided regional nerve blockade of the scalp in addition to standard general anesthesia for elective supratentorial craniotomy. The procedure targets the supratrochlear, supraorbital, auriculotemporal, postauricular branches of the greater auricular nerve, and the greater, lesser, and third occipital nerves.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
心率变化(每分钟心跳次数)
大体时间:1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) 超声/手术部位感染后 (T2) 颅骨钉置入后 (T3) 皮肤切开期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) 超声/手术部位感染后 (T2) 颅骨钉置入后 (T3) 皮肤切开期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
收缩压(SBP)变化(单位:mmHg)
大体时间:1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI后 (T2) 颅骨钉置入后 (T3) 皮肤切开时 (T4) 硬脑膜打开时 (T5) 皮肤缝合时 (T6))
1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI后 (T2) 颅骨钉置入后 (T3) 皮肤切开时 (T4) 硬脑膜打开时 (T5) 皮肤缝合时 (T6))
舒张压(DBP)变化(单位:mmHg)
大体时间:1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI 后 (T2) 颅骨钉插入后 (T3) 皮肤切口期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI 后 (T2) 颅骨钉插入后 (T3) 皮肤切口期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
平均动脉压(MAP)变化(单位:mmHg)
大体时间:1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI后 (T2) 颅骨钉插入后 (T3) 皮肤切口期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
1. 基线 2. 手术期间(诱导前 (T0) 插管后 (T1) USB/SSI后 (T2) 颅骨钉插入后 (T3) 皮肤切口期间 (T4) 硬脑膜打开期间 (T5) 皮肤缝合期间 (T6))
Postoperative pain intensity by Numeric Rating Scale (NRS)
大体时间:Immediately after shifting to the recovery room, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours

Scores range from 0 to 10, where 0 represents 'no pain' and 10 represents 'worst possible pain'. High scores indicate more pain.

Immediately after shifting to the recovery room, 1 hour, 2 hours, 3 hours, 6 hours, 12 hours, 24 hours

次要结果测量

结果测量
大体时间
24小时内硫酸吗啡总消耗量(mg)
大体时间:24小时
24小时

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年4月1日

初级完成 (估计的)

2026年10月30日

研究完成 (估计的)

2026年10月30日

研究注册日期

首次提交

2026年3月18日

首先提交符合 QC 标准的

2026年3月22日

首次发布 (实际的)

2026年3月27日

研究记录更新

最后更新发布 (实际的)

2026年9月30日

上次提交的符合 QC 标准的更新

2026年9月28日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • #6026

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅